Ulcerative Colitis Clinical Trials in Dallas, Texas

6 studies are recruiting for ulcerative colitis in Dallas, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

    Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). This study will assess how Risankizumab moves through the body as well as how safe and effective it is in treating pediatric participants …

    Stage
    Phase 3
    Ages
    2 to 17
    Site
    University of Texas - Southwestern Medical Center /ID# 271835, Dallas, Texas
    Locations
    64 in total
    Run by
    AbbVie

    See if you can join NCT07071519 on ClinicalTrials.gov

  2. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    This phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer that has spread from …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    UT Southwestern Simmons Cancer Center - RedBird, Dallas, Texas
    Locations
    52 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT03816345 on ClinicalTrials.gov

  3. LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

    The main purpose of the study is to evaluate the effectiveness and safety of LY4268989 when given with mirikizumab compared to mirikizumab alone in adult participants with moderately to severely active ulcerative colitis (UC). Study participation will last approximately 118 weeks, including 104 wee…

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    GI Alliance - Dallas - Gaston Avenue, Dallas, Texas
    Locations
    147 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07186101 on ClinicalTrials.gov

  4. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

    This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis (UC). Study details include: The study duration may be up to 35 weeks wi…

    Stage
    Phase 3
    Ages
    16 to 80
    Site
    The University of Texas Southwestern Medical Center - Site Number: 8400098, Dallas, Texas
    Locations
    219 in total
    Run by
    Sanofi

    See if you can join NCT07184996 on ClinicalTrials.gov

  5. A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

    The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with tofacitinib in adults with moderate and severe ulcerative colitis (UC). Another aim is to learn about treatment with Vedolizumab alone after the double treatment. All participants wi…

    Stage
    Phase 4
    Ages
    18 to 65
    Site
    GI Alliance - Digestive Health Associates of Texas, Dallas, Texas
    Locations
    46 in total
    Run by
    Takeda

    See if you can join NCT06095128 on ClinicalTrials.gov

  6. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

    The purpose of this study is to compare the effectiveness and safety of a strategy of switching to an alternative targeted immunomodulator (TIM) therapy to treat to a target of endoscopic remission, versus continuing index TIM in patients with inflammatory bowel disease (IBD) (Crohn's disease or ul…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Texas Southwestern, Dallas, Texas
    Locations
    24 in total
    Run by
    Mayo Clinic

    See if you can join NCT05230173 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.